The readings this week covered a lot of information regarding patient portals, protected health information (PHI), privacy, engagement, and ethical a

The readings this week covered a lot of information regarding patient portals, protected health information (PHI), privacy, engagement, and ethical and legal responsibilities. We learned that patient-generated health data (PGHD) can increase patient engagement and the quality of care provided. We also read about the advancement of ancestry data and DNA testing platforms, which provide advanced genomic science data and the opportunity to improve population and healthcare outcomes. 

*
Outline strategies and interventions to mitigate the risk of health inequities resulting from advancements in technology and personalized medicine.

*
Discuss the pros and cons of consumer rights to their own DNA information and your role as a
graduate nurse educator, nurse leader, or nurse practitioner 
to educate and provide care. 

· Initial post must be at least 250 words and supported by 2 scholarly sources.

Writing Requirements and APA Style/Formatting

· In-text citations

· Reference list in correct APA style/formatting

· Standard English usage and mechanics

· Scholarly sources that are evidence-based, peer-reviewed, and published in the last five (5) years

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit
Reviews

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

  Read “M2 Dimick Sorting out Advance Directives_Journal of AHIMA HL.pdf” attached above. You are a Medical Records Technician at Northwestern Memorial

  Read “M2 Dimick Sorting out Advance Directives_Journal of AHIMA HL.pdf” attached above. You are a Medical Records Technician at Northwestern Memorial Hospital.  One of your tasks is applying applicable laws, policies, and procedures for ROI. For each scenario, describe the decision you render.  Answer the two questions that follow.

As a psychiatric mental health nurse practitioner (PMHNP), how do you approach the management of treatment-resistant schizophrenia, particularly in

As a psychiatric mental health nurse practitioner (PMHNP), how do you approach the management of treatment-resistant schizophrenia, particularly in cases where traditional antipsychotic medications and psychosocial interventions have been ineffective? What are the challenges and opportunities in utilizing biomarkers of inflammation to aid in the early diagnosis and personalized treatment